mani
studi
shown
activ
bcatenin
signal
promot
oncogenesi
therefor
interest
find
agent
modul
pathway
recent
work
shown
use
b
lymphoma
cell
infect
epsteinbarr
viru
ebv
express
latent
membran
protein
lmp
caus
increas
express
bcatenin
cellular
transform
convers
result
cellbas
small
molecul
screen
studi
shown
antibiot
hexachlorophen
downregul
bcatenin
colon
cancer
cell
report
hexachlorophen
also
counteract
elev
bcatenin
level
ebvinfect
b
lymphoma
associ
restor
level
ubiquitin
ligas
activ
bcatenin
regul
diminish
result
suggest
target
hexachlorophen
opposit
effect
hexachlorophen
modul
bcatenin
independ
result
reduc
express
cmyc
target
gene
bcatenin
lead
growth
arrest
b
lymphoma
cell
result
propos
hexachlorophen
may
provid
novel
therapeut
strategi
ebvinfect
b
lymphoma
cell
reduc
bcatenin
level
via
restor
mani
studi
shown
wntbcatenin
signal
pathway
play
import
role
cell
prolifer
differenti
oncogenesi
particular
abnorm
upregul
wntbcatenin
activ
frequent
detect
earli
event
mani
cancer
level
bcatenin
normal
regul
part
target
decay
mediat
glycogen
synthas
depend
pathway
altern
pathway
pathway
bcatenin
phosphoryl
multiprotein
complex
compos
apc
axin
lead
degrad
bcatenin
ubiquitindepend
mechan
convers
pathway
interact
carboxyl
terminu
apc
recruit
ubiquitin
complex
promot
degrad
bcatenin
pathway
independ
btrcp
fbox
protein
ubiquitin
ligas
complex
report
focus
behavior
b
cell
lymphoma
known
infect
epsteinbarr
viru
ebv
member
human
herp
viru
famili
enhanc
transform
normal
rest
b
cell
indefinit
prolifer
lymphoblastoid
cell
line
earlier
work
see
front
matter
elsevi
ireland
ltd
right
reserv
shown
latent
membran
protein
lmp
ebv
transform
rodent
fibroblast
vitro
induc
lymphoma
transgen
mice
thu
consid
import
multifunct
oncoprotein
caus
dysregul
cell
signal
pathway
induc
varieti
cellular
gene
enhanc
cell
surviv
adhes
invas
angiogen
potenti
exampl
oncoprotein
appear
mimic
cellular
molecul
lead
interact
traf
protein
culmin
activ
nfjb
jnk
studi
shown
also
activ
stat
molecul
jak
interact
recent
report
elev
bcatenin
protein
level
downregul
ubiquitin
ligas
screen
chemic
librari
undertaken
identifi
small
molecul
inhibitor
bcatenin
activ
yield
one
potenti
candid
hexachlorophen
antimicrobi
compound
use
disinfect
surgic
scrub
hexachlorophen
inhibit
activ
enoylacyl
carrier
protein
reductas
last
enzym
fatti
acid
elong
cycl
target
antibacteri
agent
hexachlorophen
also
inhibitor
proteas
sarscov
report
suppress
bcatenin
level
upregul
colon
cancer
cell
thu
want
combin
dispar
observ
ask
whether
hexachlorophen
might
effect
diminish
elev
level
bcatenin
achiev
activ
ebvinfect
b
lymphoma
establish
mechan
might
occur
observ
consequ
cell
behavior
report
hexachlorophen
inde
suppress
level
bcatenin
ebvinfect
b
lymphoma
appar
rescu
ubiquitin
ligas
result
thu
rais
possibl
hexachlorophen
similar
compound
may
ultim
use
treatment
ebvmedi
b
lymphoma
bjab
ramo
raji
b
lymphocyt
cultur
rpmi
supplement
fb
penicillin
streptomycin
bjab
b
cell
electropor
lg
dna
v
lf
biorad
hercul
ca
cell
harvest
h
electropor
express
protein
determin
immunoblot
hexachlorophen
licl
sigma
st
loui
mo
cyclohexamid
provid
calbiochem
san
diego
ca
antibtubulin
anticmyc
hrpconjug
secondari
antibodi
purchas
santa
cruz
santa
cruz
ca
antibcatenin
antibodi
obtain
bd
bioscienc
san
jose
ca
detect
protein
cosmobio
tokyo
japan
dako
carpinteria
ca
antibodi
use
respect
ptopflash
pfopflash
report
plasmid
obtain
upstat
biotechnolog
lake
placid
ny
total
rna
extract
cell
use
trizol
reagent
invitrogen
carlsbad
ca
accord
manufactur
instruct
three
microgram
total
rna
convert
cdna
use
superscript
ii
revers
transcriptas
invitrogen
pcr
perform
use
specif
primer
describ
elsewher
cdna
sampl
dilut
pcr
run
optim
cycl
number
bactin
mrna
measur
intern
standard
amplif
product
subject
electrophoresi
agaros
detect
ethidium
bromid
stain
bjab
b
cell
cell
electropor
topflash
fopflash
report
vector
normal
transfect
effici
pgkbgal
vector
express
bgalactosidas
phosphoglucokinas
promot
includ
transfect
mixtur
h
posttransfect
cell
wash
cold
pb
lyse
lysi
solut
mm
tri
ph
mm
edta
mm
dtt
glycerol
triton
luciferas
activ
measur
luminomet
use
luciferas
kit
promega
madison
wi
cell
harvest
lyse
lysi
buffer
nacl
nonidet
mm
tri
ph
contain
mm
na
vo
mm
naf
proteas
inhibitor
sigma
immunoblot
protein
whole
cell
lysat
resolv
sdspage
transfer
nitrocellulos
membran
primari
antibodi
use
dilut
secondari
hrpconjug
antibodi
santa
cruz
use
dilut
nonfat
dri
milk
final
wash
nitrocellulos
membran
expos
use
chemiluminesc
assay
geamersham
piscataway
nj
describ
elsewher
cell
cultur
mm
plate
wash
harvest
icecold
pb
cell
pellet
lyse
ttn
buffer
mm
trishcl
ph
triton
mm
nacl
mm
edta
mm
dtt
glycerol
mm
pmsf
cocktail
proteas
inhibitor
ice
min
follow
centrifug
min
supernat
taken
solubl
fraction
pellet
insolubl
fraction
subsequ
solubil
ripa
buffer
mm
trishcl
ph
mm
nacl
mm
edta
mm
dtt
deoxychol
acid
sd
glycerol
mm
pmsf
cocktail
proteas
inhibitor
ice
min
centrifug
min
thereaft
supernat
use
nuclear
extract
explor
whether
infect
b
cell
ebv
induc
upregul
bcatenin
examin
raji
b
lymphoma
cell
persist
infect
ebv
plu
bjab
ramo
lymphoma
cell
free
ebv
infect
ebv
confirm
express
primari
oncogen
protein
raji
b
cell
fig
figur
also
show
protein
level
ubiquitin
ligas
decreas
wherea
bcatenin
protein
level
enhanc
raji
cell
comparison
level
higher
bcatenin
level
lower
bjab
ramo
b
cell
test
whether
instead
viral
protein
specif
link
upregul
bcatenin
downregul
express
protein
bjab
cell
use
electropor
vector
found
express
alon
suffici
reduc
protein
level
lead
upregul
bcatenin
fig
addit
determin
whether
increas
bcatenin
due
introduct
transcript
activ
transfect
cell
report
plasmid
contain
wildtyp
topflash
mutant
fopflash
bind
site
tcf
presenc
absenc
seen
fig
express
specif
induc
tcf
report
activ
indic
least
bcatenin
transcript
activ
examin
whether
also
downregul
mrna
level
measur
mrna
bjab
cell
presenc
absenc
use
rtpcr
seen
fig
presenc
downregul
mrna
level
dosedepend
manner
result
suggest
reduc
protein
mrna
level
taken
togeth
propos
express
induc
upregul
bcatenin
downregul
hexachlorophen
identifi
screen
small
molecul
librari
inhibitor
bcatenin
possibl
use
treatment
colon
cancer
therefor
examin
whether
hexachlorophen
also
downregul
high
level
bcatenin
observ
ebvinfect
b
lymphoma
shown
fig
b
hexachlorophen
significantli
downregul
protein
well
mrna
level
bcatenin
level
dosedepend
manner
furthermor
hexachlorophen
treatment
reduc
tcf
transcript
activ
dose
depend
manner
fig
next
examin
whether
proteosom
involv
downregul
bcatenin
follow
treatment
hexachlorophen
administ
proteosom
inhibitor
hexachlorophenetr
cell
analyz
bcatenin
level
found
bcatenin
level
restor
compar
cell
treat
hexachlorophen
fig
suggest
downregul
bcatenin
mediat
hexachlorophen
achiev
via
proteosom
activ
interest
introduct
cycloheximid
inhibitor
protein
synthesi
also
partli
restor
bcatenin
level
hexachlorophenetr
cell
fig
suggest
aspect
protein
synthesi
requir
activ
bcatenin
degrad
pathway
sinc
observ
hexachlorophen
administr
caus
decreas
protein
level
bcatenin
fig
next
investig
mechan
downregul
might
achiev
seen
fig
hexachlorophen
also
induc
upregul
level
associ
decreas
bcatenin
ebvinfect
b
cell
lane
confirm
featur
mediat
express
also
introduc
express
vector
bjab
cell
treat
hexachlorophen
found
hexachlorophen
treatment
rescu
decreas
level
mediat
result
upregul
bcatenin
fig
next
sinc
phosphoryl
bcatenin
follow
associ
btrcp
lead
independ
bcatenin
degrad
test
whether
might
cooper
regul
bcatenin
howev
found
inhibit
use
licl
caus
increas
bcatenin
protein
level
without
affect
level
b
cell
fig
lane
suggest
protein
directli
involv
signal
pathway
howev
coadministr
licl
hexachlorophen
caus
protein
level
bcatenin
still
elev
fig
lane
b
cell
suggest
effect
licl
induct
bcatenin
inhibit
overrid
hexachlorophen
ebvinfect
b
lymphoma
suggest
express
activ
tumor
suppressor
lead
induct
apoptosi
cellcycl
arrest
mammalian
cell
addit
genotox
reagent
doxorubicin
may
suppress
bcatenin
respons
transcript
pathway
involv
explor
issu
investig
whether
hexachlorophen
treatment
might
influenc
transcript
cell
contain
wildtyp
seen
fig
neither
hexachlorophen
doxorubicin
treatment
affect
transcript
abund
furthermor
examin
protein
level
treatment
hexachlorophen
found
chang
protein
level
even
lm
hexachlorophen
wherea
doxorubicin
induc
upregul
abund
fig
addit
determin
whether
increas
due
treatment
hexachlorophen
enhanc
transcript
activ
target
gene
transfect
cell
luciferas
report
vector
contain
target
sequenc
bind
protein
seen
fig
hexachlorophen
increas
transcript
activ
doxorubicin
drastic
enhanc
transcript
activ
target
result
suggest
hexachlorophen
induc
express
independ
pathway
activ
first
examin
express
bcatenin
target
gene
cmyc
nuclear
extract
sever
line
evid
shown
nuclear
local
cmyc
preferenti
detect
prolifer
tumorigen
cell
seen
fig
express
level
cmyc
diminish
nuclear
extract
compar
express
hexachlorophen
dosedepend
manner
h
posttreat
group
report
shrna
chemic
inhibit
bcatenin
induc
retard
tumor
cell
growth
explor
potenti
biolog
consequ
reduc
bcatenin
level
achiev
treatment
hexachlorophen
examin
viabl
cell
ebv
posit
b
lymphoma
observ
strike
dosedepend
decreas
viabl
cell
number
b
lymphoma
cell
h
treatment
hexachlorophen
fig
result
suggest
hexachlorophen
decreas
express
bcatenindepend
gene
lead
growth
arrest
b
lymphoma
cell
excess
accumul
bcatenin
frequent
detect
variou
type
cancer
colorect
ovarian
endometri
prostat
cancer
primari
effus
lymphoma
cell
express
kaposi
sarcoma
associ
herp
viru
kshv
also
show
elev
bcatenin
level
particular
lana
protein
kshv
play
crucial
role
upregul
bcatenin
sequestr
downregul
might
distinct
action
show
primari
oncoprotein
ebv
also
induc
upregul
bcatenin
b
lymphocyt
decreas
protein
mrna
level
known
target
ubiquitin
proteosom
degrad
may
affect
protein
destabil
addit
downregul
mrna
level
indic
might
inhibit
transcript
gene
although
promot
region
recent
identifi
work
requir
establish
detail
inhibit
transcript
consequ
overexpress
bcatenin
target
gene
includ
cmyc
matrix
peroxisom
proliferatorsactiv
receptord
play
import
role
tumorigenesi
constitut
activ
bcatenin
signal
therefor
potenti
target
chemoprevent
treatment
variou
cancer
includ
b
cell
lymphoma
furthermor
report
hexachlorophen
drastic
suppress
bcatenin
level
pathway
rather
pathway
ebvinfect
b
lymphoma
hexachlorophen
specif
upregul
mrna
protein
b
lymphoma
counteract
downregul
furthermor
prolong
exposur
ebvinfect
b
lymphoma
cell
hexachlorophen
also
induc
apoptot
cell
death
downregul
bcatenin
target
gene
express
howev
upregul
bcatenin
licl
inhibit
overrid
hexachlorophen
ebvinfect
b
lymphoma
fig
sinc
previou
work
show
hexachlorophen
inhibit
express
bcatenin
induc
licl
cell
differ
respons
two
cell
type
current
investig
interest
observ
cycloheximid
restor
bcatenin
level
hexachlorophenetr
cell
fig
suspect
stabil
protein
involv
regul
bcatenin
express
also
critic
factor
degrad
cycloheximid
treatment
may
contribut
recoveri
bcatenin
point
subject
studi
group
propos
induc
tumor
suppressor
activ
contribut
cellcycl
arrest
tumor
suppress
apoptosi
howev
hexachlorophen
affect
either
transcript
translat
level
studi
suggest
exist
anoth
hexachlorophenerespons
pathway
regul
recent
report
show
also
promot
degrad
bcatenin
upregul
level
consist
suggest
sinc
hexachlorophen
suppress
wntbcatenin
signal
manner
possibl
potenti
therapeut
strategi
may
effect
cancer
cell
mutant
commonli
found
mani
cancer
resist
genotox
chemotherapeut
previou
search
small
molecul
inhibitor
bcatenin
activ
reveal
candid
block
interact
bcatenin
camp
respons
elementbind
protein
inhibit
associ
bcatenin
complex
contrast
hexachlorophen
specif
reduc
amount
free
bcatenin
protein
independ
pathway
degrad
result
propos
hexachlorophen
could
ultim
provid
potenti
therapeut
strategi
treatment
ebvinfect
b
lymphoma
